v3.25.3
Cover - $ / shares
9 Months Ended
Sep. 30, 2025
Nov. 12, 2025
Document Type 10-Q/A  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2025  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41293  
Entity Registrant Name ASPIRE BIOPHARMA HOLDINGS, INC.  
Entity Central Index Key 0001847345  
Entity Tax Identification Number 33-3467744  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 23150 Fashion Drive, Suite 232  
Entity Address, Address Line Two Suite 232  
Entity Address, City or Town Estero  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33928  
City Area Code (908)  
Local Phone Number 987-3002  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   107,477,178
Entity Listing, Par Value Per Share $ 0.0001  
Common Stock, par value $0.0001 per share [Member]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol ASBP  
Security Exchange Name NASDAQ  
Warrants, each exercisable for one share of common stock [Member]    
Title of 12(b) Security Warrants, each exercisable for one share of common stock  
Trading Symbol ASBPW  
Security Exchange Name NASDAQ